MediMan

MediMan

Helthcare Anytime. Anywhere.

tisankan
@tisankan
Published on Mar 18, 2026
Visit site
0 PeerPush
🚀
Awarded
Just Launched
PeerPush

Details

Follow on
Platforms

Discovery signals

How AI and people discover MediMan on PeerPush

Read by AI engines 30dEngines readingHow many times AI crawlers read this listing, and which engines those crawlers belong to.
145
  • ChatGPT
  • Claude
  • Perplexity
  • +3 other AI crawlers

Reads by these AI engines

Crawlers behind these engines read this listing on PeerPush.
PersistenceRead streakConsecutive days, counting back from today, that AI has read this listing every single day.
9 days

Read by AI every day

Read by AI every day for the last 9 days.
Search index 90dSearch indexTimes a search engine AI indexer, such as OAI-SearchBot, crawled this listing.
15 crawls

ChatGPT Search indexer

By OAI-SearchBot, the ChatGPT Search indexer, in the last 90 days.

About MediMan

MediMan is a global telehealth platform for finding doctors, booking appointments, and completing consultations online. Patients can search by specialty, view availability, and consult through video, voice, or chat based on provider settings. After the visit, doctors can issue digital prescriptions and share care notes, so patients keep everything organized in one place. MediMan also supports lab bookings and report access, enabling patients to upload results and track follow ups across multiple visits. Integrated in app payments and automated reminders help reduce no shows and make the entire flow smoother for both patients and providers. Designed to scale across regions, MediMan helps patients access trusted medical care faster, reduces waiting time, and improves continuity of care with a simple, secure experience.

Screenshots

Screenshot 1 of MediMan
Screenshot 2 of MediMan
Screenshot 3 of MediMan
Screenshot 4 of MediMan
Screenshot 5 of MediMan
Screenshot 6 of MediMan
Screenshot 7 of MediMan
Screenshot 8 of MediMan

Reviews (0)

No reviews yet. Be the first to rate this product!

Comments (0)

No comments yet. Be the first to share your thoughts!